If your child needs a stronger prescription year after year, you are not alone, and acting on it is exactly the right instinct. The faster a child's nearsightedness progresses, the higher their lifetime risk of serious eye problems like retinal detachment and glaucoma, which is why slowing it matters. Mudgil Eye Associates offers myopia control for Bryn Mawr families about 25 minutes away via Route 30 and Route 252, with both FDA-approved MiSight contact lenses and low-dose atropine, guided by a Johns Hopkins fellowship-trained pediatric ophthalmologist and a residency-trained pediatric optometrist. We are a complete MD-and-OD team, so if anything beyond myopia ever comes up, expert care is already in place.
Bryn Mawr sits near the center of the Main Line, straddling Lower Merion Township in Montgomery County and Radnor and Haverford Townships in Delaware County, with Lancaster Avenue running straight through the middle of it. It is a town shaped by education, from Bryn Mawr College and Harcum College to a dense cluster of independent and public schools, which means a great many local children spend long days on close work. Families here in Bryn Mawr, Haverford, Rosemont, Gladwyne, and the surrounding Lower Merion neighborhoods often make the roughly 25-minute drive west toward our West Chester office after watching a child's prescription creep upward at each annual exam. Curbing that upward creep is exactly what a myopia control plan sets out to accomplish.
Myopia control is not a one-time product but a plan that unfolds over years, one we measure, adjust, and monitor as your child grows. Amid screen-filled classrooms, heavier reading demands, and fewer daylight hours than earlier generations spent outdoors, more Bryn Mawr children are becoming nearsighted at younger ages than their parents did. In an academically intense community, that pattern shows up early and often. Because Mudgil Eye Associates unites a residency-trained pediatric optometrist and a Johns Hopkins fellowship-trained pediatric ophthalmologist in one practice, whatever your child's eyes turn out to need is already within reach.
MiSight is an FDA-approved daily contact lens proven to slow the progression of myopia in children. Your child wears it during the day, and it both corrects vision and helps keep the prescription from climbing as quickly. We are listed on the manufacturer's official provider locator.
Dr. A. Vijay Mudgil completed his pediatric ophthalmology fellowship at the Wilmer Eye Institute, Johns Hopkins, and our optometrist provides residency-trained pediatric care. Your child's myopia plan is overseen by pediatric eye specialists who do this every day.
For children who are not ready for contact lenses, we also offer low-dose atropine eye drops, a simple nightly drop widely used to help slow myopia progression. We help you choose the approach that fits your child best, and some children do well with a combination.
We are a complete MD-and-OD practice. A fellowship-trained pediatric ophthalmologist works alongside our optometrist, so if your child ever needs more than myopia control, a pediatric ophthalmologist's expertise is already part of their care.
Nearsightedness may seem like nothing more than a fuzzy view across a room and a trip for new glasses, but the true change runs deeper. In a myopic eye, the eyeball has grown a touch too long from front to back, a shift called axial elongation. Because that length carries the retina too far back, distant light comes to a focus just short of it, blurring far objects while close ones stay sharp. Glasses and everyday contacts bend the light back onto target, yet they do nothing about the eye's length or how fast it keeps growing. Reining in that growth is the entire purpose of myopia control.
The stakes go well beyond a slimmer lens at the next visit. Every step deeper into nearsightedness means a longer, more stretched eye and a higher lifetime chance of retinal detachment, glaucoma, cataract arriving earlier, and myopic maculopathy in adult life. By tempering how fast the myopia builds while a child is still growing, we work toward a lower adult prescription, and a lower prescription translates to lower long-term risk. We are careful to say that myopia control does not cure or reverse the nearsightedness already present, and results vary from child to child, but for most children it slows the pace in a way that counts.
Childhood myopia is trending upward across the country, and the Main Line is not spared. Heredity weighs heavily, so a child with one or two nearsighted parents starts out more likely to follow suit, but everyday habits matter as well. Extended near focus for homework, reading, and screens, coupled with fewer hours outdoors in daylight, correlates with faster progression. In a town as academically driven as Bryn Mawr, near work adds up quickly, which is why protecting a steady dose of outdoor time is among the simplest evidence-supported moves a family can make. We treat daily habits as a genuine part of the plan and not a footnote.
When a Bryn Mawr child is old enough and ready to take on a contact lens, MiSight 1 day is often our opening recommendation. It is the only soft contact lens the FDA has cleared expressly to slow myopia progression in children, and because it is a daily-disposable lens worn during waking hours, it sharpens vision on its own, so there are no daytime glasses to lose between school and the practice field.
To the wearer, a MiSight lens feels like any ordinary soft contact, but it is engineered with concentric treatment zones. The central zone gives clean distance vision while the surrounding zones bring some light to a focus just in front of the peripheral retina, a cue that appears to calm the eye's push to keep growing longer. In the manufacturer's multi-year clinical study, children in MiSight progressed far more slowly on average than a comparison group, on the order of a 59 percent reduction in the rate of progression over three years. That number is a clinical-study result, and each child's benefit will look a little different.
MiSight generally fits school-age and older children, often beginning around ages 8 to 12, who are mature enough to insert, remove, and care for a lens with a parent's help early on. Because a fresh lens goes in each day and is discarded at night, there is no solution or case to track. A significant amount of astigmatism can rule a child out, something Dr. Julakanti checks carefully at the fitting. For the lens to work as intended, it needs to be worn most of the day, generally ten or more hours a day, six or more days a week, until the eyes finish growing and the prescription settles.
Parents in Bryn Mawr frequently ask us about a treatment that does not require their child to handle a contact lens at all: a small drop placed in each eye at bedtime. Low-dose atropine has become one of the most discussed approaches to slowing childhood myopia, and for the right child it can be a straightforward and well-tolerated option. An atropine consultation is a common reason Bryn Mawr families make the drive out to our West Chester office.
Atropine is a long-established eye medication. At the very low concentrations used for myopia control, commonly between 0.01% and 0.05%, it is used off-label to slow the elongation of a child's eye over time. This is a different purpose and a far weaker strength than the dilating drops used during a routine eye exam, which is why the everyday side effects most people associate with atropine are usually minimal at these low doses.
The appeal for many Bryn Mawr parents is the simplicity. A single drop is placed in each eye at night, often as part of the bedtime routine, and the child wears their normal glasses during the day. There are no lenses to insert, clean, or store. Because the dose is low, many children notice little to no change in how their eyes feel, though some may experience slight light sensitivity or a small effect on close focus, which we monitor and can adjust for by changing the concentration.
One reason atropine works well as a managed, primary treatment is that the strength can be tailored. We may begin at a lower concentration and adjust based on how a child's prescription responds over the following months. This is not a set-and-forget medication; it is a plan that Dr. Mudgil and our optometric team revisit at follow-up visits, watching both the rate of progression and how comfortably the child tolerates the drop.
Atropine is one of two evidence-based tools we depend on, and occasionally the two are combined. MiSight 1 day contact lenses, FDA-approved to slow progression in children roughly ages 8 to 12, suit families comfortable with daily lens wear. Atropine often becomes the lead choice for younger children, for kids not yet ready for contacts, or for families who simply prefer a nightly drop. Slowing progression with either method matters because higher myopia carries a greater lifetime risk of retinal detachment, glaucoma, and myopic maculopathy.
MiSight 1 day lenses and low-dose atropine drops are each proven, evidence-based ways to slow how quickly a child's nearsightedness advances. Neither cures myopia, and neither behaves the same in every child, so the right choice follows your child rather than a rigid formula. As we decide, we weigh age and maturity, the current prescription and how briskly it is moving, comfort with wearing a contact, the degree of astigmatism, everyday activities, and your family's preferences.
Broadly speaking, MiSight suits an older, contact-lens-ready child who would also welcome a break from daytime glasses, while low-dose atropine suits a younger child, a child not yet ready for lenses, or a family that favors a simple nightly drop with glasses during the day. Some children begin with one approach and change to the other as they mature, and in select cases the two are combined. Whatever we choose, myopia control remains a managed plan: at regular visits we measure the prescription, and where it helps the length of the eye, then adjust the plan as time goes on. Results vary from child to child, and our goal is the best possible outcome for yours.
The best moment to begin myopia control is early in the progression, while the eye is still growing and more future change can still be prevented. In practice that is often the first time a child needs distance glasses, or the first time a prescription jumps between yearly exams. Myopia most often appears between about ages 8 and 12, though it can begin earlier, and a Bryn Mawr child with nearsighted parents or a fast-moving prescription deserves a closer look sooner rather than later. No referral is needed to schedule an evaluation.
Most nearsighted children are candidates for some form of myopia control. The clearest hints that it is time to reach out include a prescription that climbs at every visit, squinting or moving close to the board or television, frequent headaches or eye strain, and a family history of high myopia. Only a full evaluation can show which option fits, and part of our job is to tell you honestly whether myopia control is likely to help your child and which approach makes the most sense.
A myopia control evaluation is a thorough pediatric eye exam, not a quick screening. We measure your child's vision and full prescription, often with dilating drops for accuracy, check eye alignment and overall eye health, and record baseline measurements so we can follow progression precisely as the years pass. Then we sit down with you and your child, put the findings in plain language, and lay out the choices, including what each treatment involves day to day, what it can and cannot do, and the follow-up schedule. If a contact lens is the plan, we fit it and teach your child how to handle it. Plan on the visit running a bit longer than a routine exam, especially when drops are used.
Myopia management works best as a long-term relationship, and at Mudgil Eye Associates your child gains an unusually complete team. Dr. Reetu R. Julakanti, our residency-trained pediatric optometrist, leads the day-to-day myopia control program for Bryn Mawr families, fitting MiSight lenses, prescribing and adjusting low-dose atropine, and following each child's progress across the years of treatment. Optometrists are the foundation of children's vision care, and Dr. Julakanti's focused pediatric training is precisely what a growing, shifting prescription requires.
Beside her stands Dr. A. Vijay Mudgil, a board-certified, fellowship-trained pediatric ophthalmologist who completed his pediatric ophthalmology and strabismus fellowship at the Wilmer Eye Institute at Johns Hopkins and has cared for Chester County families for more than 20 years. He has been named a Main Line Today Top Doctor since 2009. Having an optometrist and a fellowship-trained pediatric ophthalmologist in the same practice means that if your child ever needs more than myopia control, from a difficult prescription to eye misalignment or a medical concern, that expertise is already on the team, with no new referral and no starting over.
Learn more about our pediatric eye care for children of all ages, or explore our full myopia management program for Chester County families.
Yes. Dr. Reetu Julakanti, our pediatric optometrist, fits FDA-approved MiSight 1 day contact lenses for children in the Bryn Mawr area. MiSight is a soft daily-disposable lens worn during the day that corrects vision and is proven to slow the progression of myopia in children.
Both are proven, evidence-based ways to slow how fast a child's nearsightedness progresses. MiSight suits an older child ready to handle a daily contact lens; low-dose atropine, a simple nightly eye drop, suits younger children or those not ready for contacts. Dr. Julakanti helps you choose and adjusts the plan over time.
Myopia control combines proven treatments, MiSight 1 day contact lenses and low-dose atropine, with lifestyle steps like more time outdoors. Bryn Mawr-area families see Dr. Julakanti, who builds a plan for each child and monitors progress at regular visits. Slowing progression matters because higher myopia raises the lifetime risk of eye problems later in life.
Myopia control is most effective when it starts early, while the eye is still growing and the most future change can still be prevented. Many Bryn Mawr children begin between roughly ages 6 and 12, often at the first sign a prescription is rising, though there is no single right age. Because the aim is to limit change still ahead, an earlier start usually leads to a lower final prescription. If your child is newly nearsighted or the numbers keep moving, it is worth an evaluation now rather than waiting.
No. Myopia control neither cures nearsightedness nor reverses the prescription your child already has. Its role is to slow how fast the myopia progresses through the growing years, so your child ends up less nearsighted than they otherwise would. Your child will still wear glasses or contacts to see clearly, and results vary from child to child.
Neither is right for every child; the best fit depends on yours. MiSight 1 day lenses suit an older, contact-lens-ready child who would also like to be free of daytime glasses. Low-dose atropine, a simple nightly drop with glasses by day, suits younger children or those not ready for contacts. Both are evidence-based and proven to slow progression, and Dr. Julakanti helps you choose based on age, prescription, comfort with lenses, and lifestyle.
For most children it meaningfully slows the rate of progression, though it does not stop it entirely or reverse existing nearsightedness. In its multi-year clinical study, MiSight was associated with about a 59 percent reduction in the rate of progression over three years, and low-dose atropine has slowed progression across multiple studies. These are clinical-study findings; each child's benefit varies, which is why we monitor and adjust at regular visits.
It helps, as a supportive habit rather than a treatment. Daylight time outdoors is linked to a lower chance of developing myopia and, in some studies, slower progression, with roughly two hours a day a commonly cited figure. It offers no guarantee and does not replace a lens or drop once a child is progressing, but it is a healthy, low-cost habit we encourage for every child.
Yes. Myopia control generally suits active Bryn Mawr kids well. MiSight 1 day lenses correct vision without glasses, which many children prefer during games, and each lens is thrown away at night. Low-dose atropine is a bedtime drop, so it never interferes with daytime activity; the child just wears their usual glasses or sports eyewear. We are glad to discuss protective eyewear for your child's sport.
It typically continues through the growing years, until a child's eyes stop changing and the prescription holds steady, frequently in the mid-to-late teens or early adulthood. We plan any wind-down together rather than stopping abruptly, timing it to how the eyes are behaving. Regular follow-up visits remain part of the plan from start to finish.
No referral is needed to book a myopia evaluation. Coverage varies from plan to plan, and some services or materials may not be covered by medical or vision insurance, so our team goes over the specifics with you before treatment begins. Call our West Chester office at (610) 429-3004 and we will help you weigh the options.
Most Bryn Mawr families are seen within one to two weeks for an initial myopia evaluation. Call 610-429-3004 or schedule online, and we will help you get ahead of your child's nearsightedness.